Stereoselective HPLC separation of alvimopan on cellulose‐based immobilized polysaccharide as a chiral stationary phase
Chiral separation by normal phase high performance liquid chromatography is one of the most powerful technique to quantify the chiral purity of the compounds. In this study, a novel, simple, and specific analytical method was proposed to ascertain the chiral purity of alvimopan (ALV). The normal pha...
Saved in:
Published in | Chirality (New York, N.Y.) Vol. 30; no. 8; pp. 982 - 987 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.08.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Chiral separation by normal phase high performance liquid chromatography is one of the most powerful technique to quantify the chiral purity of the compounds. In this study, a novel, simple, and specific analytical method was proposed to ascertain the chiral purity of alvimopan (ALV). The normal phase HPLC method was developed based on cellulose tris (3,5‐dichlorophenylcarbamate) stationary phase. The separation of ALV isomers achieved by using column CHIRALPAK IC (250 × 4.6 mm, 5 μm), mobile phase n‐hexane: isopropyl alcohol: ethanol: diethylamine (650:200:150:5 v/v), column oven temperature 30°C, flow rate 1.0 mL min−1, injection volume was 10 μL, chromatographic response monitored at 273 nm. The developed method was validated as per the ICH guidelines and found precise, accurate, and linear. The advantage of the method is a good separation of ALV isomers within 35 minutes of the analysis time. Therefore, this method is suitable for routine determination of chiral purity of ALV active pharmaceutical ingredient. |
---|---|
AbstractList | Chiral separation by normal phase high performance liquid chromatography is one of the most powerful technique to quantify the chiral purity of the compounds. In this study, a novel, simple, and specific analytical method was proposed to ascertain the chiral purity of alvimopan (ALV). The normal phase HPLC method was developed based on cellulose tris (3,5‐dichlorophenylcarbamate) stationary phase. The separation of ALV isomers achieved by using column CHIRALPAK IC (250 × 4.6 mm, 5 μm), mobile phase n‐hexane: isopropyl alcohol: ethanol: diethylamine (650:200:150:5 v/v), column oven temperature 30°C, flow rate 1.0 mL min−1, injection volume was 10 μL, chromatographic response monitored at 273 nm. The developed method was validated as per the ICH guidelines and found precise, accurate, and linear. The advantage of the method is a good separation of ALV isomers within 35 minutes of the analysis time. Therefore, this method is suitable for routine determination of chiral purity of ALV active pharmaceutical ingredient. Chiral separation by normal phase high performance liquid chromatography is one of the most powerful technique to quantify the chiral purity of the compounds. In this study, a novel, simple, and specific analytical method was proposed to ascertain the chiral purity of alvimopan (ALV). The normal phase HPLC method was developed based on cellulose tris (3,5-dichlorophenylcarbamate) stationary phase. The separation of ALV isomers achieved by using column CHIRALPAK IC (250 × 4.6 mm, 5 μm), mobile phase n-hexane: isopropyl alcohol: ethanol: diethylamine (650:200:150:5 v/v), column oven temperature 30°C, flow rate 1.0 mL min , injection volume was 10 μL, chromatographic response monitored at 273 nm. The developed method was validated as per the ICH guidelines and found precise, accurate, and linear. The advantage of the method is a good separation of ALV isomers within 35 minutes of the analysis time. Therefore, this method is suitable for routine determination of chiral purity of ALV active pharmaceutical ingredient. Chiral separation by normal phase high performance liquid chromatography is one of the most powerful technique to quantify the chiral purity of the compounds. In this study, a novel, simple, and specific analytical method was proposed to ascertain the chiral purity of alvimopan (ALV). The normal phase HPLC method was developed based on cellulose tris (3,5‐dichlorophenylcarbamate) stationary phase. The separation of ALV isomers achieved by using column CHIRALPAK IC (250 × 4.6 mm, 5 μm), mobile phase n‐hexane: isopropyl alcohol: ethanol: diethylamine (650:200:150:5 v/v), column oven temperature 30°C, flow rate 1.0 mL min−1, injection volume was 10 μL, chromatographic response monitored at 273 nm. The developed method was validated as per the ICH guidelines and found precise, accurate, and linear. The advantage of the method is a good separation of ALV isomers within 35 minutes of the analysis time. Therefore, this method is suitable for routine determination of chiral purity of ALV active pharmaceutical ingredient. Chiral separation by normal phase high performance liquid chromatography is one of the most powerful technique to quantify the chiral purity of the compounds. In this study, a novel, simple, and specific analytical method was proposed to ascertain the chiral purity of alvimopan (ALV). The normal phase HPLC method was developed based on cellulose tris (3,5-dichlorophenylcarbamate) stationary phase. The separation of ALV isomers achieved by using column CHIRALPAK IC (250 × 4.6 mm, 5 μm), mobile phase n-hexane: isopropyl alcohol: ethanol: diethylamine (650:200:150:5 v/v), column oven temperature 30°C, flow rate 1.0 mL min-1 , injection volume was 10 μL, chromatographic response monitored at 273 nm. The developed method was validated as per the ICH guidelines and found precise, accurate, and linear. The advantage of the method is a good separation of ALV isomers within 35 minutes of the analysis time. Therefore, this method is suitable for routine determination of chiral purity of ALV active pharmaceutical ingredient. Abstract Chiral separation by normal phase high performance liquid chromatography is one of the most powerful technique to quantify the chiral purity of the compounds. In this study, a novel, simple, and specific analytical method was proposed to ascertain the chiral purity of alvimopan (ALV). The normal phase HPLC method was developed based on cellulose tris (3,5‐dichlorophenylcarbamate) stationary phase. The separation of ALV isomers achieved by using column CHIRALPAK IC (250 × 4.6 mm, 5 μm), mobile phase n‐hexane: isopropyl alcohol: ethanol: diethylamine (650:200:150:5 v /v), column oven temperature 30°C, flow rate 1.0 mL min −1 , injection volume was 10 μL, chromatographic response monitored at 273 nm. The developed method was validated as per the ICH guidelines and found precise, accurate, and linear. The advantage of the method is a good separation of ALV isomers within 35 minutes of the analysis time. Therefore, this method is suitable for routine determination of chiral purity of ALV active pharmaceutical ingredient. |
Author | Komaravolu, Yagnakirankumar Gunjal, Dattatray B. Hima Bindu, K. Gore, Anil H. Kolekar, Govind B. Dhekale, Nitin H. |
Author_xml | – sequence: 1 givenname: Nitin H. orcidid: 0000-0003-3976-3307 surname: Dhekale fullname: Dhekale, Nitin H. organization: Dr. Reddy's Laboratories Ltd. Hyderabad – sequence: 2 givenname: Dattatray B. surname: Gunjal fullname: Gunjal, Dattatray B. organization: Shivaji University – sequence: 3 givenname: Anil H. surname: Gore fullname: Gore, Anil H. organization: Rajarshi Chhatrapati Shahu College Kolhapur – sequence: 4 givenname: Yagnakirankumar orcidid: 0000-0002-8914-7265 surname: Komaravolu fullname: Komaravolu, Yagnakirankumar organization: Dr. Reddy's Laboratories Ltd. Hyderabad – sequence: 5 givenname: K. surname: Hima Bindu fullname: Hima Bindu, K. organization: Dr. Reddy's Laboratories Ltd. Hyderabad – sequence: 6 givenname: Govind B. surname: Kolekar fullname: Kolekar, Govind B. email: gbkolekar@yahoo.co.in organization: Shivaji University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29782664$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kctu1DAUhi1URKeFDQ-ALLFBSCnHjhMnSzQCptJIIC4Su8iXE40rJw520mpY8Qg8Y5-knk5hwYKVbek7n87v_4ycjGFEQp4zuGAA_I3ZuXjBeVO1j8iKVRyKuqy_n5AVNG1bAAh-Ss5SugKAti7FE3LKW9nwuhYrsv8yY8SQ0KOZ3TXSzaftmiacVFSzCyMNPVX-2g1hUvkxUoPeLz4P3P76rVVCS90wBO28-5nvU_D7pIzZqegsUpWooof1lKdpvhequKfTLg8-JY975RM-ezjPybf3776uN8X244fL9dttYcpKtkVTN0KDUcyyppIS61pZoa2Sfa9FpUuLIEzPwULfS0DBtLSMa1YaqFrgTXlOXh29Uww_FkxzN7h0SKFGDEvqeP4fKVopZUZf_oNehSWOebtMSV6CbAAy9fpImRhSith3U3RDztUx6A6FdIfE3X0hGX7xoFz0gPYv-qeBDLAjcOM87v-j6taby89H6R19Y5pk |
CitedBy_id | crossref_primary_10_1002_chir_23082 crossref_primary_10_1016_j_trac_2019_07_011 crossref_primary_10_1016_j_chroma_2021_461878 crossref_primary_10_1016_j_jpba_2018_12_035 crossref_primary_10_1002_chir_23050 |
Cites_doi | 10.1097/MJT.0b013e31804c6f37 10.1016/j.jpba.2011.06.011 10.1016/0021-9673(94)00803-5 10.1016/S0021-9673(00)99941-2 10.1016/j.jpba.2012.10.017 10.1101/cshperspect.a002147 10.1016/0021-9673(94)80400-1 10.1016/j.chroma.2004.04.040 10.1097/01.sla.0000232538.72458.93 10.1021/jm00041a003 10.1017/CBO9780511535468 10.1016/S0002-9610(01)00784-X 10.1016/S0021-9673(00)93965-7 10.1111/j.1365-2982.2005.00640.x 10.1002/(SICI)1521-3773(19980504)37:8<1020::AID-ANIE1020>3.0.CO;2-5 10.1067/mcp.2001.112680 10.1016/j.aca.2005.06.044 10.1056/NEJMoa010564 |
ContentType | Journal Article |
Copyright | 2018 Wiley Periodicals, Inc. |
Copyright_xml | – notice: 2018 Wiley Periodicals, Inc. |
DBID | NPM AAYXX CITATION 7QO 7QR 7U7 8FD C1K FR3 P64 7X8 |
DOI | 10.1002/chir.22859 |
DatabaseName | PubMed CrossRef Biotechnology Research Abstracts Chemoreception Abstracts Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef Biotechnology Research Abstracts Technology Research Database Toxicology Abstracts Chemoreception Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Biotechnology Research Abstracts PubMed MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1520-636X |
EndPage | 987 |
ExternalDocumentID | 10_1002_chir_22859 29782664 CHIR22859 |
Genre | article Journal Article |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 29B 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABIJN ABOCM ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACIWK ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AI. AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BTSUX BY8 CS3 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRSTM DU5 EBD EBS EJD F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M21 MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG P2W P2X P4D PALCI Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RWK RX1 RYL SAMSI SUPJJ TUS UB1 UPT V2E V8K VH1 W8V W99 WBFHL WBKPD WIB WIH WIK WJL WOHZO WQJ WRC WXSBR WYISQ XG1 XV2 YCJ ZZTAW ~02 ~IA ~WT NPM AAYXX CITATION 7QO 7QR 7U7 8FD C1K FR3 P64 7X8 |
ID | FETCH-LOGICAL-c3579-8684b0ca1d18577e66ad4bda7ffb45b3de04cf20d0ff70e41b7d12b13c0590283 |
IEDL.DBID | DR2 |
ISSN | 0899-0042 |
IngestDate | Sat Aug 17 03:48:56 EDT 2024 Thu Oct 10 15:57:16 EDT 2024 Fri Aug 23 03:56:07 EDT 2024 Sat Nov 02 12:17:07 EDT 2024 Sat Aug 24 00:59:15 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | alvimopan method validation method development stereoselective HPLC |
Language | English |
License | 2018 Wiley Periodicals, Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3579-8684b0ca1d18577e66ad4bda7ffb45b3de04cf20d0ff70e41b7d12b13c0590283 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-3976-3307 0000-0002-8914-7265 |
PMID | 29782664 |
PQID | 2072307800 |
PQPubID | 986330 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_2042749777 proquest_journals_2072307800 crossref_primary_10_1002_chir_22859 pubmed_primary_29782664 wiley_primary_10_1002_chir_22859_CHIR22859 |
PublicationCentury | 2000 |
PublicationDate | August 2018 |
PublicationDateYYYYMMDD | 2018-08-01 |
PublicationDate_xml | – month: 08 year: 2018 text: August 2018 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Chichester |
PublicationTitle | Chirality (New York, N.Y.) |
PublicationTitleAlternate | Chirality |
PublicationYear | 2018 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 1994; 685 1998; 37 2007; 245 1994; 666 2005; 550 2001; 182 1987; 411 2013; 74 2008 2008; 15 2004; 1041 1994; 37 2004 2011; 56 1975; 112 2002 2010; 2 2005; 17 2001; 13 2001; 69 e_1_2_6_21_1 e_1_2_6_20_1 e_1_2_6_9_1 e_1_2_6_8_1 Lough WJ (e_1_2_6_10_1) 2002 e_1_2_6_19_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_13_1 e_1_2_6_14_1 e_1_2_6_3_1 e_1_2_6_11_1 e_1_2_6_2_1 e_1_2_6_12_1 e_1_2_6_22_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_15_1 e_1_2_6_16_1 |
References_xml | – volume: 2 start-page: a002147 year: 2010 article-title: The origin of biological homochirality publication-title: Cold Spring Harb Perspect Biol – volume: 550 start-page: 123 year: 2005 end-page: 129 article-title: Development and validation of HPLC methods for enantioseparation of mirtazapine enantiomers at analytical and semipreparative scale using polysaccharide chiral stationary phases publication-title: Anal Chim Acta – volume: 15 start-page: 59 year: 2008 end-page: 65 article-title: New therapies in the treatment of postoperative ileus after gastrointestinal surgery publication-title: Am J of Ther – volume: 411 start-page: 139 year: 1987 end-page: 151 article-title: Resolution of enantiomeric aromatic alcohols on a cellulose tribenzoate high‐performance liquid chromatography chiral stationary phase: a proposed chiral recognition mechanism publication-title: J Chromatogr – volume: 685 start-page: 349 year: 1994 end-page: 355 article-title: Direct enantiomeric separation of the four stereoisomers of nadolol using normal phase and reversal‐cease high performance liquid chromatography with Chiralpak AD publication-title: J Chromatogr – volume: 1041 start-page: 119 year: 2004 end-page: 133 article-title: Definition and system implementation of strategies for method development of chiral separations in normal‐ or reversed‐phase liquid chromatography using polysaccharide‐based stationary phases publication-title: J of Chromatogr A – volume: 112 start-page: 37 year: 1975 end-page: 60 – volume: 666 start-page: 403 year: 1994 end-page: 419 article-title: Resolution by high‐performance liquid chromatography using polysaccharide carbamates and benzoates as chiral stationary phases publication-title: J Chrom A – year: 2002 – year: 2008 – volume: 37 start-page: 1020 year: 1998 article-title: Polysaccharide derivatives for chromatographic separation of enantiomers publication-title: Angew Chem Int Ed – year: 2004 – volume: 56 start-page: 521 year: 2011 end-page: 537 article-title: Chiral separations in normal‐phase liquid chromatography: enantioselectivity of recently commercialized polysaccharide based selectors. Part II. Optimization of enantioselectivity publication-title: J Pharm Biomed Anal – volume: 37 start-page: 2262 year: 1994 end-page: 2265 article-title: Discovery of a potent, peripherally selective trans‐3, 4‐Dimethyl‐4‐(3‐hydroxyphenyl) piperidine opioid antagonist for the treatment of gastrointestinal motility disorders publication-title: J of Medi Chem – volume: 13 start-page: 935 year: 2001 end-page: 940 article-title: Selective postoperative inhibition of gastrointestinal opioid receptors publication-title: The New Eng J of Medicine – volume: 245 start-page: 355 year: 2007 end-page: 363 article-title: Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies publication-title: Ann Surg – volume: 17 start-page: 157 issue: 2 year: 2005 end-page: 165 article-title: Alvimopan, a selective peripherally acting μ‐opioid antagonist publication-title: Neurogas Motility – volume: 74 start-page: 111 year: 2013 end-page: 116 article-title: Fundamental study of enantioselective HPLC separation of tapentadol enantiomers using cellulose‐based chiral stationary phase in normal phase mode publication-title: J Phar Bio Ana – volume: 182 start-page: 27S issue: suppl year: 2001 end-page: 38S article-title: Alvimopan (ADL 8‐2698) is a novel peripheral opioid antagonist publication-title: The American J of Surg – volume: 69 start-page: 66 year: 2001 end-page: 71 article-title: Jr ADL 8‐2698, a trans‐3,4‐dimethyl‐4‐(3‐hydroxyphenyl) piperidine, prevents gastro‐intestinal effects of intravenous morphine without affecting analgesia publication-title: Clin Pharmacol Ther – ident: e_1_2_6_8_1 doi: 10.1097/MJT.0b013e31804c6f37 – ident: e_1_2_6_18_1 doi: 10.1016/j.jpba.2011.06.011 – ident: e_1_2_6_14_1 doi: 10.1016/0021-9673(94)00803-5 – ident: e_1_2_6_19_1 doi: 10.1016/S0021-9673(00)99941-2 – ident: e_1_2_6_15_1 doi: 10.1016/j.jpba.2012.10.017 – ident: e_1_2_6_12_1 doi: 10.1101/cshperspect.a002147 – ident: e_1_2_6_20_1 doi: 10.1016/0021-9673(94)80400-1 – volume-title: Chirality in Natural and Applied Science year: 2002 ident: e_1_2_6_10_1 contributor: fullname: Lough WJ – ident: e_1_2_6_13_1 doi: 10.1016/j.chroma.2004.04.040 – ident: e_1_2_6_9_1 doi: 10.1097/01.sla.0000232538.72458.93 – ident: e_1_2_6_4_1 doi: 10.1021/jm00041a003 – ident: e_1_2_6_11_1 doi: 10.1017/CBO9780511535468 – ident: e_1_2_6_3_1 doi: 10.1016/S0002-9610(01)00784-X – ident: e_1_2_6_22_1 doi: 10.1016/S0021-9673(00)93965-7 – ident: e_1_2_6_2_1 doi: 10.1111/j.1365-2982.2005.00640.x – ident: e_1_2_6_6_1 – ident: e_1_2_6_21_1 doi: 10.1002/(SICI)1521-3773(19980504)37:8<1020::AID-ANIE1020>3.0.CO;2-5 – ident: e_1_2_6_5_1 doi: 10.1067/mcp.2001.112680 – ident: e_1_2_6_16_1 doi: 10.1016/j.aca.2005.06.044 – ident: e_1_2_6_17_1 – ident: e_1_2_6_7_1 doi: 10.1056/NEJMoa010564 |
SSID | ssj0009634 |
Score | 2.2650042 |
Snippet | Chiral separation by normal phase high performance liquid chromatography is one of the most powerful technique to quantify the chiral purity of the compounds.... Abstract Chiral separation by normal phase high performance liquid chromatography is one of the most powerful technique to quantify the chiral purity of the... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 982 |
SubjectTerms | Alcohols alvimopan Cellulose Ethanol Flow rates Flow velocity High performance liquid chromatography HPLC Ions Isomers Isopropanol Isopropyl alcohol Liquid chromatography method development method validation Polysaccharides Purity Separation Stationary phase stereoselective Stereoselectivity |
Title | Stereoselective HPLC separation of alvimopan on cellulose‐based immobilized polysaccharide as a chiral stationary phase |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fchir.22859 https://www.ncbi.nlm.nih.gov/pubmed/29782664 https://www.proquest.com/docview/2072307800 https://search.proquest.com/docview/2042749777 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NatwwEB5CLsmlzU9_tkmLQksPBW9sWbbWkEvYJGxKW0raQC7FaGSZLNnaS7wb2JzyCHnGPklH0nqXpFBobzKS0EgajT7JM58A3sVk8zJtogAlx0BkSgUYaTKGOiGwQHu-dkFhn7-kg3Px8SK5WIGDNhbG80MsLtzsynD22i5whc3-kjRUXw6vu9zyr5EBjmJp_bmOzpbcUaRZjjuqZ8PsSTUX3KR8f1n14W70B8R8iFjdlnPyFH60wnpPk6vudIJdffuIx_F_e7MBT-ZYlB165dmEFVNtwfZhRefwnzP2njnvUHftvgVr_fZluG2YfaPJMHXjntAha8kGXz_1WWM8jXhdsbpkanRDWkCmhtG3_TswHVGFX3f3dtss2JDU37rl3lJ6XI9mjdI2_mtYGKYappgVlERrvKMAdYuNL6niMzg_Of7eHwTzJxwCHScyC3ppT2CoVVRYzilp0lQVAgslyxJFgnFhQqFLHhZhWcrQiAhlEXGMYu15ZeLnsFrVlXkJjJCOSSVXWKISSKiOck2GWZolhDJQdOBtO5X52DN15J6TmedW6NyNbgd221nO56u1yXkorT88YecO7C2yaVDt8KjK1FNbRtABntCy7MALrx2LZjgdxQnokAgf3Bz_pf28Pzg9c6lX_1J4B9YJqfW85-EurE6up-Y1oaEJvnFa_xvYDwex |
link.rule.ids | 315,783,787,1378,27936,27937,46306,46730 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB5BOZRLKS3QLQWMQByQsk0cJ94cq4UqhW2FSiv1FtmOo67YJqtmF2l74hF4Rp6kM_b-qCAhwc2RbflvZvzZGX8D8DZGm5cZGwVach2ITKlARwaNoUkQLOCeb9yjsOOTND8Xny6Si7lvDr2F8fwQyws30gxnr0nB6UJ6f8Uaai6H111OBGz34QHqe0yRGz6crtijULYce1SPHtqjcC7ZSfn-qu7d_egPkHkXs7pN5_CRj6zaOq5C8jX51p1OdNfc_Mbk-N_j2YSNORxlB15-HsM9W2_B9kGNR_GrGXvHnIOou3nfgvX-IjjcNsy-4nrYpnVRdNBgsvzLoM9a65nEm5o1FVOj7ygIaG0YftMPgukIK_z68ZN2zpINUQPIM_cG0-NmNGuVoSdgw9Iy1TLFqKPYtdb7CuC42PgSKz6B88OPZ_08mEdxCEycyCzopT2hQ6OikminpE1TVQpdKllVWiQ6Lm0oTMXDMqwqGVoRaVlGXEex8dQy8VNYq5va7gBDsGNTyZWutBIagR3m2kxnaZYg0NCiA28Wa1mMPVlH4WmZeUGdLtzsdmBvsczFXGHbgoeSXOIRPnfg9TIbJ5WmR9W2mVIZgWd4BMyyA8-8eCyb4XgaR6yDXXjvFvkv7Rf9_OjUpXb_pfArWM_PjgfF4Ojk83N4iMCt5x0R92Btcj21LxAcTfRLpwK3MlULyQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFD7ahsS4YewHKAxmBOJiUrrEceJG4mYqVB2MaRpM2g2K_BetoiTV0iJ1VzzCnnFPsmO7aTWQkLY7R7blY_v4-LNzzmeAdzHavEyZKJCcyoBlQgQyUmgMVYJgAfd85YLCvh6l_VP2-Sw5W4IPTSyM54eYX7jZleHstV3gI13sLUhD1fngok0t_9oyPGApQl8LiU4W5FGoWo48qmPj7FE35-SkdG9R9_Z29A_GvA1Z3Z7TW4MfjbTe1eRnezKWbXX5F5HjfbvzBB7PwCjZ99qzDkum3IDN_RIP4r-m5D1x7qHu3n0DVrvN03CbMP2Gs2Gq2r2hg-aS9I8Pu6Q2nke8KklVEDH8jWqAtobgt_09MBlihes_V3bf1GSA-m_9ci8xPaqG01ooGwA20IaImghiBUXRau8pgN0io3OsuAWnvU_fu_1g9oZDoOKEZ0En7TAZKhFpSzrFTZoKzaQWvCgkS2SsTchUQUMdFgUPDYsk1xGVUaw8sUz8FFbKqjTPgSDUMSmnQhZSMImwDnNNJrM0SxBmSNaCt81U5iNP1ZF7UmaaW6FzN7ot2G5mOZ8t1zqnIbcO8QieW_Bmno2DaodHlKaa2DIMT_AIl3kLnnntmDdD8SyOSAdF2HVz_J_2827_4MSlXtyl8A48PP7Yyw8Pjr68hEeI2jreC3EbVsYXE_MKkdFYvnYL4AYRogp4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Stereoselective+HPLC+separation+of+alvimopan+on+cellulose-based+immobilized+polysaccharide+as+a+chiral+stationary+phase&rft.jtitle=Chirality+%28New+York%2C+N.Y.%29&rft.au=Dhekale%2C+Nitin+H&rft.au=Gunjal%2C+Dattatray+B&rft.au=Gore%2C+Anil+H&rft.au=Komaravolu%2C+Yagnakirankumar&rft.date=2018-08-01&rft.eissn=1520-636X&rft_id=info:doi/10.1002%2Fchir.22859&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0899-0042&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0899-0042&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0899-0042&client=summon |